Core Laboratories Inc. (NYSE:CLB - Free Report) - Zacks Research increased their Q4 2027 earnings per share estimates for Core Laboratories in a report released on Wednesday, November 18th. Zacks Research analyst Team now anticipates that the oil and gas company will post earnings per share of $0.23 for the quarter, up from their prior estimate of $0.22. The consensus estimate for Core Laboratories' current full-year earnings is $0.56 per share. Zacks Research also issued estimates for Core Laboratories' Q1 2028 earnings at $0.26 EPS and Q2 2028 earnings at $0.32 EPS.
Other analysts have also issued research reports about the stock. Weiss Ratings lowered shares of Core Laboratories from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Friday, November 13th. Wall Street Zen upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research note on Saturday, August 1st. Finally, Johnson Rice upgraded shares of Core Laboratories from a "hold" rating to a "buy" rating and set a $21.00 target price for the company in a research note on Thursday, August 13th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $21.00.
Read Our Latest Analysis on CLB
Core Laboratories Stock Down 0.8%
Shares of NYSE:CLB opened at $8.38 on Friday. The company has a quick ratio of 1.60, a current ratio of 2.19 and a debt-to-equity ratio of 0.40. Core Laboratories has a 52-week low of $8.12 and a 52-week high of $20.36. The company has a 50 day moving average of $10.05 and a two-hundred day moving average of $13.20. The company has a market capitalization of $384.11 million, a price-to-earnings ratio of 22.06, a price-to-earnings-growth ratio of 1.70 and a beta of 1.18.
Core Laboratories (NYSE:CLB - Get Free Report) last announced its earnings results on Wednesday, October 28th. The oil and gas company reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $132.08 million for the quarter, compared to the consensus estimate of $131.87 million. Core Laboratories had a return on equity of 8.94% and a net margin of 3.42%. The company's revenue was down 1.8% on a year-over-year basis. During the same period last year, the business posted $0.22 EPS.
Core Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Monday, November 9th will be paid a $0.01 dividend. The ex-dividend date is Monday, November 9th. This represents a $0.04 annualized dividend and a dividend yield of 0.5%. Core Laboratories's payout ratio is 10.53%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Aquatic Capital Management LLC raised its position in shares of Core Laboratories by 206.6% in the 3rd quarter. Aquatic Capital Management LLC now owns 57,644 shares of the oil and gas company's stock valued at $559,000 after purchasing an additional 38,843 shares in the last quarter. Archon Capital Management LLC grew its position in shares of Core Laboratories by 152.1% during the third quarter. Archon Capital Management LLC now owns 450,475 shares of the oil and gas company's stock worth $4,370,000 after buying an additional 271,775 shares in the last quarter. Jump Financial LLC increased its stake in shares of Core Laboratories by 50.5% in the third quarter. Jump Financial LLC now owns 180,700 shares of the oil and gas company's stock worth $1,753,000 after buying an additional 60,649 shares during the last quarter. Heartland Advisors Inc. increased its stake in shares of Core Laboratories by 5.8% in the third quarter. Heartland Advisors Inc. now owns 1,119,900 shares of the oil and gas company's stock worth $10,863,000 after buying an additional 61,589 shares during the last quarter. Finally, Voya Investment Management LLC bought a new stake in shares of Core Laboratories in the third quarter worth $98,000. Hedge funds and other institutional investors own 97.81% of the company's stock.
About Core Laboratories
(
Get Free Report)
Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company's Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.